NURO | NeuroMetrix, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.80 - 4.01
52 Week Range	2.6600 - 4.73
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	28,307
Average Volume	21,815
Shares Outstanding	2,042,690
Market Cap	7,966,491
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2004-07-22

Valuation
Profitability
Growth
Health
P/E Ratio	-0.86
Forward P/E Ratio	N/A
EPS	-4.51
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	26
Country	USA
Website	NURO

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.

NURO's peers: CODX, IINN, HSCS, RSLS, OPGN, BBLG, NUWE, TIVC, TLIS, NAOV, BJDX, VVOS, THMO, SINT, RMED

*Chart delayed

Analyzing fundamentals for NURO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see NURO Fundamentals page.

Watching at NURO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on NURO Technicals page.